B-cell prolymphocytic leukemia (B-PLL) is a rare lymphoproliferative disorder with clinical, morphologic, and immunophenotypic features that overlap with other mature B-cell leukemias and lymphomas. Patients with B-PLL typically have marked splenomegaly and leukocytosis, have no significant ...
Cases of B-PLL withMYCaberration and 17p (TP53) deletion have the worst prognosis. Abstract B-cell prolymphocytic leukemia (B-PLL) is a rare hematological disorder whose underlying oncogenic mechanisms are poorly understood....
Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia. We describe a patient with leukopenic T-cell chronic lymphocytic leukemia/prolymphocytic leukemia (T-CLL/PLL), according to the Revised European-American C... A Miyata,K Kojima,T...
Development of B-cell prolymphocytic leukemia in a patient with splenic diffuse red pulp small B-cell lymphomaNK/T-cell lymphomas which are characterized by the biphenotype of the NK-cell and the T-cell are divided into nasal and non-nasal NK/T-cell lymphoma, non-nasal NK/T-cell lymphoma...
IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL). B-prolymphocytic leukemia (B-PLL) is a rare disease with poor prognosis. To further characterize the biological features of this disease, we analyzed immun... Del,Giudice...
Idelalisib-Rituximab results in considerable toxicity but induces durable clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukemiaTransformation of chronic lymphocytic leukaemia (CLL) to DLBCL (Richter's syndrome, (RS)... TA Eyre,CP Fox,B Ali,... - 《British Journal of ...
Jensen M, Winkler K, Manzke O, Diehl V, Engert A: Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hematol 1998;77:89–91. ...
Monoclonal antibody, rituximab, administration for the treatment of resistant B-prolymphocytic leukemia B-cell prolymphocytic leukemia (B-PLL) is a rare lymphoid neoplasm with an aggressive clinical course. Treatment strategies for B-PLL remain to be establis... SN Tsiara,G Vartholomatos,H Kapsali...
Monoclonal antibody, rituximab, administration for the treatment of resistant B-prolymphocytic leukemiaMonoclonal antibody, rituximab, administration for the treatment of resistant B-prolymphocytic leukemiaTsiara, S NVartholomatos, GKapsali, HPritsivelis, NPappas...
A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia by Alparslan Merdin 1,*, Jale Yildiz 1, Mehmet Sinan Dal 1, Merih Kızıl Çakar 1, Hikmetullah Batgi 1, Emre Tekgündüz 1, Aykut Onursever 2 and Fevzi Altuntaş 1 1 Hematology Clinic and Bone Marr...